Pulse steriod treatment of polymyalgia rheumatica [9]

Clinical and Experimental Rheumatology

Volumn 22, Issue 3, 2004, Pages 381-382

  Cimmino, Marco A ^c   Macchioni, P ^a   Boiardi, L ^a   Cantini, F ^b   Pulsatelli, L ^b   Salvarani, C ^a  

^a Servizio di Reumatologia   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; TENIDAP; GLUCOCORTICOID;

DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; GENE EXPRESSION; HUMAN; LABORATORY TEST; LETTER; PRIORITY JOURNAL; RECURRENCE RISK; RHEUMATIC POLYMYALGIA; SIDE EFFECT; SYMPTOMATOLOGY; BLOOD; CLINICAL TRIAL; DRUG PULSE THERAPY; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PILOT STUDY; TREATMENT OUTCOME;

GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-6; PILOT PROJECTS; POLYMYALGIA RHEUMATICA; PULSE THERAPY, DRUG; TREATMENT OUTCOME;

EID: 2342474570     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. GABRIEL SE, SUNKU J, SALVARANI C, O'FALLON WM, HUNDER GG: Adverse outcomes of anti-inflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum 1997; 40: 1873-8.
2. SALVARANI C, CANTINI F, OLIVIERI I et al.: Corticosteroid injections in polymyalgia rheumatica: a double blind, prospective, randomized, placebo controlled study. J Rheumatol 2000; 27: 1470-6.
3. DASGUPTA B, DOLAN AL, PANAYI GS, FERNANDES L: An initially double-blind controlled 96 week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica. Br J Rheumatol 1998; 37: 189-95.
4. CAPORALI R, CIMMINO MA, FERRACCIOLI GF, GERLI R, SALVARANI C, MONTECUCCO C: Can methotrexate be used as a steroid-sparing agent in the treatment of polymyalgia rheumatica ? Preliminary results of a randomized, double blind, placebo-controlled study. Arthritis Rheum 2001; 44 (Suppl.): S383.
5. De SILVA M, HAZLEMAN BL: Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double blind study. Ann Rheum Dis 1986; 45: 136-8.
6. LITTMAN BH, BJARNASON D, BRYANT G et al.: Steroid sparing activity of tenidap in patients with polymyalgia rheumatica: A multicenter double blind randomized placebo controlled study. J Rheumatol 1995; 22: 1097-103.
7. BOUMPAS DT: A novel action of glucocorticoids - NF-κB inhibition. Br J Rheumatol 1996; 35: 709-10.
8. BUTTGEREIT F, WEHLING M, BURMESTER GR: A new hypothesis of modular glucocorticoid actions. Steroid treatment of rheumatic diseases revisited. Arthritis Rheum 1998; 41: 761-7.
9. JONES JG, HAZLEMAN BL: Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981; 40: 1-5.
10. CHEVALET P, BARRIER JH, POTTIER P et al.: A randomized, multicenter, controlled trial using intravenous pulse of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year follow-up study of 164 patients. J Rheumatol 2000; 27: 1484-91.